X0206 3 2014-06-19 0 0001510580 Kite Pharma, Inc. KITE 0001198321 CHAMPSI FARAH C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404 1 0 0 0 Director Stock Option (Right to Buy) 1.35 2014-03-25 2024-03-24 Common Stock 50000 D Series A Convertible Preferred Stock Common Stock 2158545 I See Foonote 1/36th of the shares subject to the stock option vested immediately, and the remaining shares vest in 35 equal monthly installments commencing March 31, 2014. The Series A Convertible Preferred Stock is convertible on a 1-for-1 basis and has no expiration date. The securities are held of record by Alta Partners VIII, L.P. ("APVIII"). Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein. /s/ Farah Champsi 2014-06-19